熱門資訊> 正文
Prenetics收入增长,提升2026年前景
2026-06-10 22:39
- Prenetics Global (PRE) on Wednesday reported first-quarter revenue of $36M and raised its 2026 IM8 revenue forecast to $190M-$210M from $180M-$200M, citing strong demand for its health supplements brand.
- The company said IM8 revenue rose 23% sequentially to $33.8M in the reported quarter and reached a record $16.7M in May, implying about $200M in annualized recurring revenue. It expects second-quarter revenue of $46M-$48M.
- The company reported a $23.1M loss for the reported quarter.
- Prenetics also said it fully exited its digital asset holdings for $41.3M, ended March debt-free with $56M in cash, and appointed supplements industry veteran Brian Rosin as CFO of IM8.
- The company plans to launch new hydration, creatine, and kids' gummies products in the fourth quarter.
- Stock down -8%
More on Prenetics Global
- Prenetics Global: Quarterly Subscription Focus Could Turn $120M AAR Into A Billion-Dollar Machine
- Prenetics Global: On Course To Hit Profitability Amid Globalization Drive
- Prenetics Global reports Q1 results; gives Q2 and raises FY26 outlook
- Seeking Alpha’s Quant Rating on Prenetics Global
- Historical earnings data for Prenetics Global
風險及免責提示:以上內容僅代表作者的個人立場和觀點,不代表華盛的任何立場,華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前,應結合自身情況,考慮投資產品的風險。必要時,請諮詢專業投資顧問的意見。華盛不提供任何投資建議,對此亦不做任何承諾和保證。